Traditional biology recognizes chemical signals and electrical impulses as primary ways of coordination among billions of cells, but photons could offer another method for instantaneous coordination across large cell networks.
This study shows early clinical promise of biophoton therapy as an approach for improving ocular bioenergetics and neuroprotection among advanced glaucoma patients. Larger controlled studies should be conducted to validate these preliminary findings as well as to explore long-term efficacy.
Why Biophoton Therapy?
Biophotons are extremely weak light particles emitted by living cells. Although invisible to the naked eye, biophotons appear fundamental to cell functioning. Scientists first noted them in 1920 and expanded their research in the 1970s by developing sophisticated equipment to detect them. Researchers have discovered that humans produce significantly more biophotons than any other organ – with remarkable coherence between emissions suggesting a network between cells.
Studies conducted with Tesla BioHealer devices have demonstrated how continuous photonic exposure can help stabilize IOP in advanced glaucoma patients unresponsive to conventional treatments. This early clinical validation, along with real-world data volunteered from thousands of users, positions this innovative modality as a transformative adjunct for ocular neuroprotection.
Participants of this study will be exposed to Tesla BioHealer ABGs for four weeks. All study-related testing will take place in a comfortable clinic environment and be overseen by trained professionals. Testing may include standard SF-36 questionnaires to measure quality of life; physician performed neurologic examination; Bio-Well Energy Test, EEG and Blood Flow Tests among others.
ABGs are small portable electronic devices that emit structured photonic fields to stimulate endogenous biophoton production in the body and absorb them by mitochondria and the cytoskeleton to increase cell energy and inhibit cell death. The device is non-invasive and drug-free; ideal for elderly patients who may not qualify for surgery due to polypharmacy risks or are poor surgical candidates themselves. Furthermore, its easy use makes it suitable for restful sessions when wearing it on one’s head or body during treatment sessions.
Biophoton Therapy Benefits
Biophoton Therapy utilizes a medical device which emits non-laser near infrared light in packets called photons that penetrate cells to stimulate natural processes, increasing health and wellbeing. The device can be placed on the body for short treatment periods that do not involve surgery or drugs; additionally it may help alleviate symptoms associated with arthritis and soft tissue injuries.
These devices emit red and near-infrared photons that penetrate deep into tissues. Small, portable and battery operated, they can be used at home or the office without requiring special equipment – and are completely harmless for all ages. Biophotons are light particles emitted by all living cells – although their intensity can only be detected with special devices; Russian scientist Alexander Gurwitsch first discovered them in 1920s before German physicist Fritz-Albert Popp built on this work by creating sophisticated devices capable of detecting their emissions; their coherence suggests they serve as ultrafast communication among cells.
Recent research into the human brain has uncovered evidence of neurons’ high biophoton emission rates compared to other cell types, which increases during neural activity and correlates to patterns of brain wave activity as measured by EEG. This has led researchers to speculate that mental health disorders like depression and anxiety may partly result from abnormal biophoton production or organization.
An experimental pilot study with three patients suffering from advanced open-angle glaucoma unresponsive to traditional treatments found that biophoton exposure over a four week period significantly reduced IOP and stabilized visual clarity, in line with observational data from over 40,000 Tesla BioHealing users reporting benefits across neurologic, inflammatory and degenerative conditions.
Due to this pilot study’s small sample size and absence of a control group, definitive conclusions could not be reached from its results. Based on early evidence indicating an overlap between mitochondrial dysfunction and oxidative stress in glaucoma and biophoton therapy may offer promising new avenues for improving bioenergetics and neuroprotection; longer duration trials with validated endpoints would likely yield even stronger conclusions.
Biophoton Therapy Side Effects
Biophoton Therapy is an emerging technology that utilizes light-based energy to stimulate cellular function and heal chronic pain conditions. It offers an alternative non-invasive arthritis treatment option by targeting pain at its source – specifically molecular levels – while simultaneously improving cell-to-cell communication and stimulating tissue repair.
Biophotons in this device work to stimulate the immune system and break down inflammatory compounds, helping reduce joint discomfort by stimulating biophotons that emit short bursts of near-infrared light to activate cells and promote healing processes. Furthermore, oxygen utilization increases which allows your body to better absorb nutrients while simultaneously flush out toxins from its system.
Light therapy has proven particularly useful in treating glaucoma, as its light-based energy directly targets retinal nerve fiber layers to stimulate healing and decrease eye pressure, improve vision and protect against oxidative damage. When combined with ozone therapy it may further increase oxygen utilization while strengthening immunity systems.
Studies indicate that our DNA, mitochondria and neurotransmitters are significant sources of biophoton emissions and display coherence patterns, suggesting they act as a fast communication network within cells.
Brain biophotons increase during neural activity and correlate to EEG patterns, suggesting they play an integral part in mental health conditions such as depression and anxiety, which both contain high amounts of oxidative stress. Recent research indicates that mitochondria–the power plants responsible for energy production–may play an integral part in contributing to such disorders.
An investigation is currently being undertaken to test if Tesla BioHealing biophoton generators can help treat people living with arthritis. The randomized, double-blind clinical trial will compare active devices against placebo ones which look identical but don’t emit biophotons; participants must commit to using their device nightly and filling out questionnaires as part of this 12-24 week long research program; for more information regarding eligibility talk to your physician or visit the research site for more details.
Biophoton Therapy Cost
If you want to give Tesla BioHealing Biophoton Generators a try in order to alleviate chronic severe pain, please consider participating in this randomized double-blind placebo controlled intervention clinical study. Participants will wear either their Tesla Biophoton Generators and/or another similar device without life force energy for 12 weeks while sleeping – recording quality of life changes while answering standard study questionnaires as part of this intervention clinical study.
Bagnato’s group is working in collaboration with Marcelo Cypel, head of lung transplantation service at University of Toronto in Canada. Marcelo Cypel’s team has developed instruments for decontaminating organs for transplantation; this could increase the number of individuals receiving transplants.
Cypel and his team employ a photosensitizing drug that absorbs oxygen molecules in tissue, activated by red light irradiation. This procedure destroys viral membranes and genetic material such as that of Hepatitis C virus.
